Geographic Atrophy Secondary to Age-related Macular Degeneration Clinical Trials

17 clinical trials for Geographic Atrophy Secondary to Age-related Macular Degeneration across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration — RECRUITING · NA
• A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration — RECRUITING · PHASE1
• A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) — RECRUITING
• Phase 2 Study of ADX-038 in Participants With Geographic Atrophy — RECRUITING · PHASE2
• Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy — RECRUITING · NA
• A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration — RECRUITING · PHASE2
• A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio — RECRUITING · PHASE2
• An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) — RECRUITING · PHASE1
• Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study) — COMPLETED · PHASE2
• A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — NOT_YET_RECRUITING · PHASE2
• An open-label multiple dose safety, tolerability and exploratory efficacy clinical trial of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration — NOT_YET_RECRUITING · PHASE2
• A randomized, double masked, placebo-controlled, multicenter, dose-range finding study to assess the efficacy and safety of FWY003 in patients with geographic atrophy secondary to age-related macular degeneration — TERMINATED · PHASE2
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — COMPLETED · PHASE3
• A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Participants with Geographic Atrophy Secondary to Age-Related Macular Degeneration — TERMINATED · PHASE3
• Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort — COMPLETED
• Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe — COMPLETED · PHASE3
• A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degeneration — OTHER · PHASE3

Refine this search